No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial‐I final report

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2133|172|3|566-571

ISSN： 0007-0963

Source： BRITISH JOURNAL OF DERMATOLOGY, Vol.172, Iss.3, 2015-03, pp. : 566-571

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multicenter Selective Lymphadenectomy Trial‐I confirms the central role of sentinel node biopsy in contemporary melanoma management

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 3, 2015-03 ,pp. : 571-573

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node‐negative melanoma

By  

CANCER, Vol. 121, Iss. 10, 2015-05 ,pp. : 1628-1636

John Wiley & Sons Inc

Access to resources Recommend Favorite

Popliteal sentinel lymph node involvement in melanoma patients

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 2, 2015-08 ,pp. : 179-182

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lymphatic Drainage in Patients with Primary Cutaneous Melanoma - the Role of Lymphoscintigraphy in Sentinel Lymph Node Biopsy

By  

Current Medical Imaging Reviews, Vol. 2, Iss. 2, 2006-05 ,pp. : 261-270

Bentham Science Publishers

Access to resources Recommend Favorite

Sentinel lymph node biopsy for 102 patients with primary cutaneous melanoma at a single Japanese institute

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 10, 2015-10 ,pp. : 954-961

John Wiley & Sons Inc

Access to resources Recommend Favorite